GlassScriptPhysician profile
Linda Thi
NPI 1508699042
$856.90
in general payments reported to CMS, 2019-2025
11 companies · $799 in 2025
The $799 reported for 2025 was more than what 81% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
See the full distribution for Gerontology (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $57.90 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $467.53 | 2025 | Itind System |
| Abbvie INC. | $104.11 | 2025 | |
| Ferring Pharmaceuticals INC. | $59.89 | 2025 | Adstiladrin |
| Urogen Pharma, INC. | $43.80 | 2024-2025 | |
| Antares Pharma, INC. | $38.47 | 2025 | Xyosted |
| Dendreon Pharmaceuticals LLC | $34.86 | 2024 | Provenge |
| Astrazeneca Pharmaceuticals LP | $24.74 | 2025 | Enhertu |
| Endo USA, INC. | $22.11 | 2025 | Aveed, Xiaflex |
| Astellas Pharma US INC | $21.13 | 2025 | Xtandi |
| Sumitomo Pharma America, INC. | $20.51 | 2025 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $19.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Thi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.